UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular laryngology : A new chapter in the understanding of laryngeal diseases

HNO, 2021-09, Vol.69 (9), p.695-704

2021

Volltextzugriff (PDF)

Exploring stimulation patterns for electrical stimulation of the larynx using surface electrodes

European archives of oto-rhino-laryngology, 2019-11, Vol.276 (11), p.3153-3158

2019

Volltextzugriff (PDF)

Molekulare Laryngologie: Ein neues Kapitel im Verständnis laryngealer Erkrankungen

HNO, 2021-09, Vol.69 (9), p.695-704

2021

Volltextzugriff (PDF)

Molekulare Laryngologie: Ein neues Kapitel im Verständnis laryngealer Erkrankungen

HNO, 2021-01, Vol.69 (9), p.695-704

2021

Volltextzugriff (PDF)

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

The lancet oncology, 2017-04, Vol.18 (4), p.e228-e232

2017

Volltextzugriff (PDF)

Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment

International journal of radiation oncology, biology, physics, 2014-06, Vol.89 (2), p.392-398

2014

Volltextzugriff (PDF)

Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States

Journal of the American College of Surgeons, 2009-10, Vol.209 (4), p.425-433.e2

2009

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?

Surgical oncology clinics of North America, 2010-07, Vol.19 (3), p.649-668

2010

Volltextzugriff (PDF)

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Annals of oncology, 2018-07, Vol.29 (7), p.1541-1547

2018

Volltextzugriff (PDF)

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

The New England journal of medicine, 2016-11, Vol.375 (18), p.1738-1748

2016

Volltextzugriff (PDF)

Pontocerebellar Hypoplasia Type 1

Pediatric neurology, 2008-10, Vol.39 (4), p.286-288

2008

Volltextzugriff (PDF)

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2758-2765

2009

Volltextzugriff (PDF)

Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis

Annals of oncology, 2022-03, Vol.33 (3), p.321-329

2022

Volltextzugriff (PDF)

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Annals of oncology, 2014-02, Vol.25 (2), p.384-391

2014

Volltextzugriff (PDF)

Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2284-2293

2004

Volltextzugriff (PDF)

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540

2013

Volltextzugriff (PDF)

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Cancer cell, 2004-08, Vol.6 (2), p.117-127

2004

Volltextzugriff (PDF)

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4222-4228

2013

Volltextzugriff (PDF)

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2645-2652

2011

Volltextzugriff (PDF)

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

Annals of oncology, 2018-03, Vol.29 (3), p.654-660

2018

Volltextzugriff (PDF)

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis

Cancer cell, 2004-11, Vol.6 (5), p.459-469

2004

Volltextzugriff (PDF)

Overview of resistance to systemic therapy in patients with breast cancer

Advances in experimental medicine and biology, 2007, Vol.608, p.1

2007

Volltextzugriff (PDF)

Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2010-2017

2014

Volltextzugriff (PDF)

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Annals of oncology, 2006-05, Vol.17 (5), p.813-817

2006

Volltextzugriff (PDF)

1 – 25 von 608

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(566)
Mit Volltextzugriff
(547)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(342)
Science & Technology
(338)
Life Sciences & Biomedicine
(333)
Female
(298)
Oncology
(241)
Middle Aged
(215)
Biological And Medical Sciences
(201)
Adult
(196)
Medical Sciences
(191)
Aged
(183)
Breast Neoplasms - Drug Therapy
(170)
Breast Neoplasms - Pathology
(140)
Pharmacology. Drug Treatments
(106)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(98)
Chemotherapy
(92)
Antineoplastic Agents
(91)
Tumors
(90)
Breast Cancer
(78)
Gynecology. Andrology. Obstetrics
(65)
Mammary Gland Diseases
(64)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular laryngology : A new chapter in the understanding of laryngeal diseases

Exploring stimulation patterns for electrical stimulation of the larynx using surface electrodes

Molekulare Laryngologie: Ein neues Kapitel im Verständnis laryngealer Erkrankungen

Molekulare Laryngologie: Ein neues Kapitel im Verständnis laryngealer Erkrankungen

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment

Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States

Adjuvant Chemotherapy in Early-Stage Breast Cancer: What, When, and for Whom?

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Pontocerebellar Hypoplasia Type 1

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis

Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes

Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis

Overview of resistance to systemic therapy in patients with breast cancer

Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Suchergebnisse filtern